SPOP and Miyoshi myopathy: In HEK293 cells, SPOP overexpression results in the activation of the c-Jun N-terminal kinase (JNK) pathway, and up to 99% of renal cancer patients show an increased expression of SPOP [57], whereas in MM its expression is rather heterogeneous and its role in MM needs to be evaluated [58].